Desai Veeral 4
4 · agilon health, inc. · Filed May 11, 2023
Insider Transaction Report
Form 4
Desai Veeral
Chief Strategy & Dev. Officer
Transactions
- Exercise/Conversion
Common Stock
2023-05-09$3.00/sh+4,500$13,500→ 304,085 total - Sale
Common Stock
2023-05-09$26.15/sh−4,500$117,666→ 299,585 total - Exercise/Conversion
Options (Rights to Buy)
2023-05-09−4,500→ 1,510,000 totalExercise: $3.00Exp: 2027-04-27→ Common Stock (4,500 underlying)
Footnotes (4)
- [F1]Includes restricted stock units.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan effective September 14, 2022.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $26.03 to $26.295, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F4]These options were granted on April 27, 2017 and vested on September 14, 2021.